It has been estimated that approximately one third of US

Size: px
Start display at page:

Download "It has been estimated that approximately one third of US"

Transcription

1 THE JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE Volume 12, Number 4, 2006, pp Mary Ann Liebert, Inc. Open-Label Trial Regarding the Use of Acupuncture and Yin Tui Na in Parkinson s Disease Outpatients: A Pilot Study on Efficacy, Tolerability, and Quality of Life MARTY L. ENG, Pharm.D., 1 KELLY E. LYONS, Ph.D., 2 MICHAEL S. GREENE, Dipl. Ac. (A.A.C.M.A.), 3 and RAJESH PAHWA, M.D. 2 ABSTRACT Objectives: This study evaluates the effects of sequential tui na massage, acupuncture, and instrument-delivered qigong for patients with Parkinson disease (PD) over a 6-month period. Design: Patients received weekly treatments, which included tui na massage prior to acupuncture followed by instrument-delivered qigong. Each patient was assessed at baseline and at 6 months. Setting: The setting was an outpatient research/academic clinic for patients with PD and nonacademic acupuncture clinic. Subjects: Twenty-five (25) patients with idiopathic PD were the subjects. Outcome measures: Before and after treatment patients were evaluated with the Unified Parkinson Disease Rating Scale (UPDRS), Hoehn and Yahr Staging (H&Y), Schwab and England Activities of Daily Living (S & E), Beck Depression Inventory (BDI), Parkinson s Disease Questionnaire (PDQ-39) quality of life assessment, and patient global assessments. Results: There were no significant improvements in treatment measures; however, there was a 2.4-point worsening in UPDRS motor scores (24.0 versus 26.4, p 0.018). There was a 16% improvement in the PDQ- 39 total score (23.2 versus 19.6, p 0.044) and a 29% improvement in the BDI (9.6 versus 6.8, p 0.006). Sixteen (16) patients reported moderate to marked improvement. There were no adverse effects. Conclusions: Acupuncture is safe and well tolerated in patients with PD. Most patients reported subjective improvement. The BDI and PDQ-39 total score, measuring depression and quality of life, demonstrated some improvement, but UPDRS motor scores worsened. INTRODUCTION It has been estimated that approximately one third of US adults use some form of alternative therapy. 1,2 A study regarding the use of alternative therapy in patients with Parkinson disease (PD) reported that 40% of patients used some form of alternative therapy for the treatment of PD, and 10% of these used acupuncture. 3 However, very few studies have evaluated the role of acupuncture in the treatment of PD. 4 8 The authors evaluated the safety and efficacy of acupuncture for 6 months (24 weekly treatments) on motor symptoms, quality of life, and depression in patients with PD. 1 University of Kansas Medical Center, University of Kansas, School of Pharmacy, Department of Pharmacy Practice, Kansas City, KS. 2 University of Kansas Medical Center, Department of Neurology, Parkinson s Disease and Movement Disorder Center, Kansas City, KS. 3 Westbrooke Chiropractic and Acupuncture, Lee Summit, MO. 395

2 396 MATERIALS AND METHODS Subjects Twenty-five (25) patients were recruited from the PD clinic of the University of Kansas Medical Center, Kansas City. All patients had a diagnosis of idiopathic PD and were on stable doses of antiparkinsonian medications. Patients with dementia were excluded from the study. The study protocol and informed consent were approved by the University of Kansas Medical Center Human Subjects Committee. All patients signed written informed consent forms. The first patient was entered in the study July 10, 2000 and the final patient completed on October 2, Outcome measures Patients were evaluated before initiation of acupuncture treatment and 6 months after treatment. At baseline, all patients were evaluated with the Unified Parkinson Disease Rating Scale (UPDRS), Hoehn and Yahr staging (H & Y), Schwab and England activities of daily living scale (S&E), Beck Depression Inventory (BDI), and patient and physician clinical global impression scales in which they completed a rating of overall disability from PD categorized as none, mild, moderate, marked, or severe. In addition, all patients completed a quality of life instrument, the Parkinson s Disease Questionnaire (PDQ-39). All patients were advised not to change any of their antiparkinsonian medications during the study period and were referred to the acupuncturist (MSG) for treatment. Intervention The patients received acupuncture treatments once a week for 6 months, a total of 24 sessions. One certified acupuncturist, who has been practicing since 1975 and has over 900 hours of relevant training, performed all the acupuncture sessions. The rationale and techniques used in this study were largely based on the work of Walton-Hadlock, focusing special attention to the foot area prior to the acupuncture. 7,8 The main goal of the acupuncture sessions was aimed at restoration of qi flow in the stomach channel with adjunctive attention given to the Large Intestine Channel based on the acupuncturists impression of the patient s qi patterns. The treatment sessions began with each patient receiving a 10- minute yin tuina (Chinese energy massage) treatment to the foot corresponding to the side of the body most affected by PD. The energy massage consisted of external qi transmission via the practitioner s hands to aid in relaxing the foot muscles. Following this treatment, after the foot started to relax, mm acupuncture needles (Hua Xia; five each foot) were inserted along the entry/exit pathway from St 42 (Chongyang) to Sp 3 (Taibai) for 7 to 10 minutes to continue opening the pathways along the Stomach channel. As the energy and relaxation of the foot continued, additional mm needles were added, alternating sides of the body each treatment, one in the elbow at LI 11 (Quchi), one in the shoulder at LI 15 (Jianyu), one on the side of the nose at LI 20 (Yingxiang), one on each side of the jaw at ST 7 (Xiaguan), and one on the side of each knee at ST 36 (Tsu san li). The additional needle placement was determined and adjusted based on the individual s pattern of qi flow. Finally, a hand-held Qigong machine (manufactured by China Healthways, Inc., San Clemente, CA) was applied to each foot for a total of 10 minutes. The Qigong machine is a low-frequency electroacoustic therapeutic massager that is placed directly on the skin or clothing. It provides lowfrequency sonic stimulation in the 8 to 14 Hz range. This treatment was applied to both feet in an alternating fashion. After 6 months of acupuncture therapy baseline evaluations were repeated. Analyses Statistical analysis was performed using Wilcoxon signed rank comparisons for nonparametric data which included the UPDRS, Hoehn and Yahr, Schwab and England, and BDI and t-tests for parametric data from the PDQ-39. RESULTS Demographics Twenty-three (23) of the 25 patients completed the study. One patient withdrew because of worsening of PD symptoms and another patient was excluded from the data analyses as antiparkinsonian medication was changed during the study. There were 13 men and 10 women who received all 24 weekly treatments with a mean age of 69.3 (range, 55.3 to 78.3) and disease duration of 6.4 (range, 0.4 to 16.5). Nine patients had a disease duration 5 years and 14 5 years. Efficacy and safety ENG ET AL. Preacupuncture and postacupuncture assessment scores are shown in Table 1. Following 6 months of therapy there were no significant changes in UPDRS Mentation (Part I), UPDRS Activities of Daily Living (Part II), H & Y, or S&E. Significant changes included a 2.4-point worsening in the UPDRS Motor (Part III) (24.0 versus 26.4, p 0.018), a 16% improvement in the PDQ-39 total score (23.2 versus 19.6, p 0.044), and a 29% improvement in the BDI (9.6 versus 6.8, p 0.006). According to patient global ratings, 3 patients reported no change, 4 reported mild improvement, nine reported moderate improvement, and seven reported marked improvement. There were no significant differences between patients who reported moderate to marked improvement and patients who reported either none or mild improvement in terms of UPDRS motor scores, depression, or quality of life measures. There were no adverse effects reported from acupuncture therapy.

3 ACUPUNCTURE AND PD 397 TABLE 1. PREACUPUNCTURE AND POSTACUPUNCTURE ASSESSMENT SCORES (MEANS AND STANDARD DEVIATIONS) Baseline After acupuncture p-value UPDRS Mentation 2.3 (1.3) 2.1 (1.6) UPDRS ADL 11.5 (5.0) 10.7 (4.5) UPDRS Motor 24.0 (7.3) 26.4 (7.0) Beck Depression Inventory 9.6 (6.9) 6.8 (6.6) PDQ-Mobility 29.6 (27.8) 25.8 (24.8) PDQ-ADL 24.8 (21.2) 20.8 (17.0) PDQ-Emotional well-being 23.0 (18.6) 18.3 (16.0) PDQ-Stigma 13.9 (16.3) 12.8 (13.5) PDQ-Social support 6.5 (9.4) 5.4 (10.2) PDQ-Cognition 24.2 (15.3) 21.7 (14.7) PDQ-Communication 18.8 (15.7) 13.8 (13.2) PDQ-Bodily discomfort 30.8 (25.6) 25.4 (24.2) PDQ-Total score 23.2 (16.4) 19.6 (13.9) H & Y 2.1 (0.4) 2.1 (0.3) S & E 83.0 (8.8) 83.0 (8.2) ADL, Activities of daily living; H & Y, Hoehn and Yahr Staging; PDQ, Parkinson Disease Questionnaire; S & E, Schwab and England activities of daily living scores; UPDRS, Unified Parkinson s Disease Rating Scale. DISCUSSION The results of this pilot study suggest that acupuncture is safe and well tolerated when administered weekly for 6 months in patients with PD. However, efficacy was subjective. Subjective changes were suggested by the improvement in PDQ-39 total scores and BDI scores. The only objective measure that changed was a slight worsening in the UPDRS motor scores. The demographics of the patient population was similar to that reported in other studies of acupuncture in PD. 4 6 The mean disease duration of the authors cohort was about 1.9 years shorter than that in the Shulman et al. study and about 2 years longer than that in the Zhuang and Wang study. Chen did not report disease duration. At baseline, the authors patients had slightly higher UPDRS Mentation (2.3 versus 1.4) and UPDRS ADL scores (11.5 versus 9.5) than those seen in the Shulman et al. study. This suggests that the authors patients may have had slightly worse mental function and ADLs performance at baseline. In the present study, a 2.4-point worsening in UPDRS motor scores reached statistical significance. However, the Shulman et al. study showed a nonsignificant improvement of 1.25 points in the UPDRS motor score. Differences might be explained by differences in acupuncture methods used, duration of intervention, and potential placebo effect. However, this would need to be studied in a head-to-head controlled trial to determine if treatment differences actually exist between methods. Additionally, there were no statistically significant differences in other outcomes measured by Shulman et al. except for improvement in the Sickness Impact Profile (SIP) sleep and rest subscore. A significant limitation with both of these studies is the open-label design. Thus, patient bias and a placebo effect cannot be ruled out as factors in the improvements reported. There is a paucity of literature regarding acupuncture and the treatment of PD. Two earlier studies reported a benefit in PD with acupuncture. 5,6 Chen reported improvement in PD symptoms after three courses of treatment consisting of 10 sessions each (30 sessions total). 6 They used the Seven Acupoints of the Cranial Base acupuncture method. The Seven Acupoints were reported as GB 20 (Fengchi; bilateral), GB 12 (Wangu; bilateral), UB 10 (Tianzhu; bilateral), and Du 15 (Yamen). Adjuvant acupoints also were described. Treatment was considered effective in 65% of patients (markedly effective in 25 % and improved in 40%) and ineffective in 35%. Zhuang and Wang reported that improvement in symptoms was supported by a delay of disease progression, decrease in dosage of antiparkinsonian medications, and expectant lessening of the complications and symptoms induced by the drug side-effects. 5 They used patients receiving Western medications without acupuncture as a control group. Treatment groups and control groups were similar in demographics. Contrary to those shorter studies, the present study did not demonstrate a benefit for PD symptoms with 24 treatments given weekly for 6 months. Combined with the negative results from the Shulman et al. study, it may be suggested that treatment benefits may be early but not sustained long term. This could be assessed in a subsequent trial with more evaluation periods (1 month, 3 months, 6 months, 12 months). In the present study, prior to acupuncture, patients received a 10-minute Chinese energy massage (yin tuina) to the foot on the side of the body most affected by PD. Walton-Hadlock reported on 12 patients with PD after a nonforceful yin-type of tuina referred to as forceless spontaneous response for approximately 1 hour once a week for a minimum of 4 weeks. The basis of this treatment is that an injury to the foot is involved in the development of PD symptoms and all of their patients reported an injury to their feet. In 11 of 12, this injury was on the side in which the

4 398 PD symptoms began. All patients were reported to have an improvement in PD symptoms; however, it is not clear how improvement was measured. The technique used in the present study were similar but of much shorter duration (10 minutes versus 1 hour), and although most patients did report subjective improvement, there was no evidence of improvement in the PD rating scales. In order to determine if this type of therapy is effective for PD symptoms, a welldesigned, controlled study with objective measures of improvement is necessary. In the present study, cases with shorter disease duration ( 5 years; mean 2.2 years, range 0.4 to 5.0 years) showed similar patterns of outcomes compared to those with longer disease duration ( 5 years; mean 9.2 years, range 5.3 to 16.5 years). Those with longer disease duration were a mean of 1.9 years younger than those with shorter disease duration (68.5 versus 70.4 years). Nine (9) patients (39%) had a disease duration less than 5 years. Of these, seven (78%) showed an increase in the UPDRS motor score, which reflects worsening of motor function. Among patients in the longer disease duration group, eight (57%) showed a worsening of motor scores and an additional 14% had no change. Likewise, changes in BDI and PDQ total reflected improvements irrespective of disease duration, which suggests that disease duration may not have an influence on the treatment outcomes. One interesting observation is the potential for treatment of depression with acupuncture. In the present study, the authors reported a 2.8-point improvement in BDI that reached statistical significance (p 0.006). In the Shulman et al. study, there was a nonsignificant worsening in the BDI. 4 Other studies in non-pd patients have suggested a benefit in major depression. 9,10 In the Gallagher et al. study, 38 women were randomized in a two-phase (acute 8-week treatment and 6-month follow-up), double-blinded, controlled trial of acupuncture. 10 Women were randomized into 3 treatment groups: acupuncture specific for depression; nonspecific acupuncture not directed at depressive symptoms; and wait-list. Eventually, all women received 8 weeks of specific acupuncture treatment. Only four (24%) of the 17 patients who achieved full remission were still in full remission after 6 months of treatment with acupuncture. Roschke et al. reported in a single-blinded, placebo-controlled trial slight improvement in the depression of 70 inpatients treated with acupuncture versus placebo acupuncture and control group. 9 All patients in that study received mianserin, a tetracyclic antidepressant. Acupuncture treatment was administered three times a week over 4 weeks. In our study, only four people were taking antidepressants. Three of which experienced a decrease in BDI. The remaining 15 patients who experienced a decrease in BDI did not take antidepressants. Further, well-designed, large, randomized, controlled trials would be needed to confirm the potential benefit of acupuncture on depression in patients with PD. A significant limitation of these studies is the lack of control group with sham acupuncture such as that developed by Park et al. 11 Use of this technology as a control may help to separate out the subjective patient bias from true treatment benefits or lack thereof. Despite the lack of a control group, the present study results were similar to that of Shulman et al. 4 CONCLUSIONS After 6 months of acupuncture therapy, 70% of the patients reported moderate to marked improvement in PD symptoms. However, there were no changes in the UPDRS, H&Y, and S&E scales suggesting a lack of objective improvement in PD symptoms. In fact, there was a worsening of the UPDRS motor scores. Yet, significant improvement was seen on the BDI along with an improvement in the PDQ- 39 quality of life scale. Although subjective improvement and improvement of BDI and PDQ-39 scores were reported, one must be mindful of the potential to worsen motor symptoms. Further, controlled trials would be warranted to gain a better perspective on the risk versus benefit of treating depression with acupuncture in patients with PD versus a slight worsening in motor function. ACKNOWLEDGMENT This study was partially supported by the Parkinson s Foundation of the Heartland. REFERENCES ENG ET AL. 1. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, : Results of a follow-up national survey. JAMA 1998;280(18): Barnes P, Powell-Griner E, McFann K, Nahin R. CDC Advance Data Report #343. Complementary and alternative medicine use among adults: United States, Posted in 2004; Accessed January 12, Rajendran PR, Thompson RE, Reich SG. The use of alternative therapies by patients with Parkinson s disease. Neurology 2001;57: Shulman LM, Wen X, Weiner WJ, et al. Acupuncture therapy for the symptoms of Parkinson s disease. Mov Disord 2002;17(4): Zhuang X, Wang L. Acupuncture treatment of Parkinson s Disease a report of 29 cases. J Trad Chin Med 2000; 20(4): Chen L. Clinical observations on forty cases of paralysis agitans treated by acupuncture. J Trad Chin Med 1998;18(1): Walton-Hadlock J. Primary Parkinson s disease: The use of tuina and acupuncture in accord with an evolving hypothesis

5 ACUPUNCTURE AND PD 399 of its cause form the perspective of Chinese traditional medicine. Am J Acupunct 1998;26: Walton-Hadlock J. Primary Parkinson s disease: The use of Tuina and acupuncture in accord with an evolving hypothesis of its cause from the perspective of Chinese traditional medicine Part 2. Am J Acupunct 1999;27: Roschke J, Wolf C, Muller MJ, Wagner P, Mann K, Grozinger M, Bech S. The benefit from whole body acupuncture in major depression. J Affect Disord 2000;57(1 3): Gallagher SM, Allen JJ, Hitt SK, Schnyer RN, Manber R. Six-month depression relapse rates among women treated with acupuncture. Complement Ther Med 2001;9(4): Park J, White A, Lee H, Ernst E. Development of a new sham needle. Acupunct Med 1999;17(2): Address reprint request to: Marty L. Eng, Pharm.D. Department of Pharmacy Practice Kansas University Medical Center MS 4047, RM B Rainbow Boulevard Kansas City, KS meng@kumc.edu

6

Acupuncture: An Introduction

Acupuncture: An Introduction Acupuncture: An Introduction Acupuncture is among the oldest healing practices in the world. As part of traditional Chinese medicine (TCM), acupuncture aims to restore and maintain health through the stimulation

More information

Parkinson Disease Levodopa-Induced Dyskinesia. Christopher Kenney, MD Novartis Pharmaceuticals

Parkinson Disease Levodopa-Induced Dyskinesia. Christopher Kenney, MD Novartis Pharmaceuticals Parkinson Disease Levodopa-Induced Dyskinesia Christopher Kenney, MD Novartis Pharmaceuticals Disclosures Dr. Kenney is a full-time employee of Novartis Pharmaceuticals Corporation The opinions expressed

More information

The Role of Acupuncture with Electrostimulation in the Prozen Shoulder

The Role of Acupuncture with Electrostimulation in the Prozen Shoulder The Role of Acupuncture with Electrostimulation in the Prozen Shoulder Yu-Te Lee A. Aim To evaluate the efficacy of acupuncture with electrostimulation in conjunction with physical therapy in improving

More information

Effects of Acupuncture on Chronic Lower Back Pain. Audience: Upper Division IPHY Majors

Effects of Acupuncture on Chronic Lower Back Pain. Audience: Upper Division IPHY Majors 1 Effects of Acupuncture on Chronic Lower Back Pain Audience: Upper Division IPHY Majors Introduction: Lower back pain is the leading cause of limited physical activity and the second most frequent reason

More information

Course outline. Acupuncture in Mental Health. History of Acupuncture and Psychiatry in HK

Course outline. Acupuncture in Mental Health. History of Acupuncture and Psychiatry in HK Course outline Acupuncture in Mental Health Simon HUI Senior Physiotherapist Kwai Chung Hospital Updated evidences for using acupuncture in Mental health A literature review Local experience for using

More information

Drugs for MS.Drug fact box cannabis extract (Sativex) Version 1.0 Author

Drugs for MS.Drug fact box cannabis extract (Sativex) Version 1.0 Author Version History Policy Title Drugs for MS.Drug fact box cannabis extract (Sativex) Version 1.0 Author West Midlands Commissioning Support Unit Publication Date Jan 2013 Review Date Supersedes/New (Further

More information

Frequent headache is defined as headaches 15 days/month and daily. Course of Frequent/Daily Headache in the General Population and in Medical Practice

Frequent headache is defined as headaches 15 days/month and daily. Course of Frequent/Daily Headache in the General Population and in Medical Practice DISEASE STATE REVIEW Course of Frequent/Daily Headache in the General Population and in Medical Practice Egilius L.H. Spierings, MD, PhD, Willem K.P. Mutsaerts, MSc Department of Neurology, Brigham and

More information

Insurance Reimbursement for Reiki Sessions

Insurance Reimbursement for Reiki Sessions Insurance Reimbursement for Reiki Sessions B Y J ANE V AN D E V ELDE, RN, ND In September 2006 I received a telephone call from a nursing friend. At that time, she was working as a consultant for a case

More information

33 % of whiplash patients develop. headaches originating from the upper. cervical spine

33 % of whiplash patients develop. headaches originating from the upper. cervical spine 33 % of whiplash patients develop headaches originating from the upper cervical spine - Dr Nikolai Bogduk Spine, 1995 1 Physical Treatments for Headache: A Structured Review Headache: The Journal of Head

More information

NeuroStar TMS Therapy Patient Guide for Treating Depression

NeuroStar TMS Therapy Patient Guide for Treating Depression NeuroStar TMS Therapy Patient Guide for Treating Depression This NeuroStar TMS Therapy Patient Guide for Treating Depression provides important safety and use information for you to consider about treating

More information

PROTOCOL SYNOPSIS Evaluation of long-term opioid efficacy for chronic pain

PROTOCOL SYNOPSIS Evaluation of long-term opioid efficacy for chronic pain P a g e 1 PROTOCOL SYNOPSIS Evaluation of long-term opioid efficacy for chronic pain Clinical Phase 4 Study Centers Study Period 25 U.S. sites identified and reviewed by the Steering Committee and Contract

More information

The Role of Complementary and Alternative Medicine

The Role of Complementary and Alternative Medicine The Role of Complementary and Alternative Medicine By Leslie Mendoza Temple, MD and Cynthia A. Holmes, PhD According to Dr. Andrew Weil, Director of the Integrative Medicine program at the University of

More information

Clinical Study Synopsis

Clinical Study Synopsis Clinical Study Synopsis This file is posted on the Bayer HealthCare Clinical Trials Registry and Results website. It is provided for patients and healthcare professionals to increase the transparency of

More information

DEPRESSION CARE PROCESS STEP EXPECTATIONS RATIONALE

DEPRESSION CARE PROCESS STEP EXPECTATIONS RATIONALE 1 DEPRESSION CARE PROCESS STEP EXPECTATIONS RATIONALE ASSESSMENT/PROBLEM RECOGNITION 1. Did the staff and physician seek and document risk factors for depression and any history of depression? 2. Did staff

More information

DEPRESSION Depression Assessment PHQ-9 Screening tool Depression treatment Treatment flow chart Medications Patient Resource

DEPRESSION Depression Assessment PHQ-9 Screening tool Depression treatment Treatment flow chart Medications Patient Resource E-Resource March, 2015 DEPRESSION Depression Assessment PHQ-9 Screening tool Depression treatment Treatment flow chart Medications Patient Resource Depression affects approximately 20% of the general population

More information

Physical therapies. Massage

Physical therapies. Massage This information is an extract from the booklet, Understanding complementary therapies. You may find the full booklet helpful. We can send you a copy free see page 6. This information discusses eight physical

More information

Assessment of depression in adults in primary care

Assessment of depression in adults in primary care Assessment of depression in adults in primary care Adapted from: Identification of Common Mental Disorders and Management of Depression in Primary care. New Zealand Guidelines Group 1 The questions and

More information

Transitioning a Pain Program Away From Chronic Opioid Prescribing

Transitioning a Pain Program Away From Chronic Opioid Prescribing Transitioning a Pain Program Away From Chronic Opioid Prescribing 1 Steve (Stephen Z. Hull, M.D.) HullS@MercyME.com 2 Transitioning a Pain Program Away From Chronic Opioid Prescribing 3 30% of patients

More information

Immunex Corporation Novantrone (Mitoxantrone HCL) P&CNS Advisory Committee Briefing Document. Page 020

Immunex Corporation Novantrone (Mitoxantrone HCL) P&CNS Advisory Committee Briefing Document. Page 020 Page 020 4.0 Efficacy of Mitoxantrone in Multiple Sclerosis The efficacy of mitoxantrone in MS was demonstrated in two well-designed, randomized trials: Studies 901 and 902. The study design and efficacy

More information

Emergency Room Treatment of Psychosis

Emergency Room Treatment of Psychosis OVERVIEW The term Lewy body dementias (LBD) represents two clinical entities dementia with Lewy bodies (DLB) and Parkinson s disease dementia (PDD). While the temporal sequence of symptoms is different

More information

A blood sample will be collected annually for up to 2 years for JCV antibody testing.

A blood sample will be collected annually for up to 2 years for JCV antibody testing. Mellen Center Currently Enrolling Non-Treatment Trials STRATIFY-2 JCV Antibody Program in Patients with Relapsing Multiple Sclerosis Receiving or Considering Treatment with Tysabri Primary Investigator:

More information

Not All Clinical Trials Are Created Equal Understanding the Different Phases

Not All Clinical Trials Are Created Equal Understanding the Different Phases Not All Clinical Trials Are Created Equal Understanding the Different Phases This chapter will help you understand the differences between the various clinical trial phases and how these differences impact

More information

Kaiser Permanente Southern California Depression Care Program

Kaiser Permanente Southern California Depression Care Program Kaiser Permanente Southern California Depression Care Program Abstract In 2001, Kaiser Permanente of Southern California (KPSC) adopted the IMPACT model of collaborative care for depression, developed

More information

Biotie Therapies Oyj Biotie Therapies Corp. Varsinainen yhtiökokous 26.5.2015 Annual General Meeting 26 May 2015

Biotie Therapies Oyj Biotie Therapies Corp. Varsinainen yhtiökokous 26.5.2015 Annual General Meeting 26 May 2015 Biotie Therapies Oyj Biotie Therapies Corp. Varsinainen yhtiökokous 26.5.2015 Annual General Meeting 26 May 2015 1 Timo Veromaa President & CEO 2 Company Highlights 2014 through Q1 2015 Continued advances

More information

Comparative survey of Complementary and Alternative Medicine. (CAM) attitudes and use and resource-seeking behavior amongst

Comparative survey of Complementary and Alternative Medicine. (CAM) attitudes and use and resource-seeking behavior amongst 1 Comparative survey of Complementary and Alternative Medicine (CAM) attitudes and use and resource-seeking behavior amongst medical students, residents & faculty Désirée Lie, MD, MSEd 1 * and John Boker,

More information

PARKINSON S DISEASE IN LONG-TERM-CARE SETTINGS

PARKINSON S DISEASE IN LONG-TERM-CARE SETTINGS PARKINSON S DISEASE IN LONG-TERM-CARE SETTINGS De Anna Looper, RN CHPN Corporate Clinical Consultant / Legal Nurse Consultant Carrefour Associates L.L.C. PARKINSON S DISEASE IN LONG-TERM-CARE SETTINGS

More information

Issues Regarding Use of Placebo in MS Drug Trials. Peter Scott Chin, MD Novartis Pharmaceuticals Corporation

Issues Regarding Use of Placebo in MS Drug Trials. Peter Scott Chin, MD Novartis Pharmaceuticals Corporation Issues Regarding Use of Placebo in MS Drug Trials Peter Scott Chin, MD Novartis Pharmaceuticals Corporation Context of the Guidance The draft EMA Guidance mentions placebo as a comparator for superiority

More information

Version History. Previous Versions. Drugs for MS.Drug facts box fampridine Version 1.0 Author

Version History. Previous Versions. Drugs for MS.Drug facts box fampridine Version 1.0 Author Version History Policy Title Drugs for MS.Drug facts box fampridine Version 1.0 Author West Midlands Commissioning Support Unit Publication Date Jan 2013 Review Date Supersedes/New (Further fields as required

More information

Opioid Treatment Services, Office-Based Opioid Treatment

Opioid Treatment Services, Office-Based Opioid Treatment Optum 1 By United Behavioral Health U.S. Behavioral Health Plan, California Doing Business as OptumHealth Behavioral Solutions of California ( OHBS-CA ) 2015 Level of Care Guidelines Opioid Treatment Services,

More information

THE DEPRESSION RESEARCH CLINIC Department of Psychiatry and Behavioral Sciences Stanford University, School of Medicine

THE DEPRESSION RESEARCH CLINIC Department of Psychiatry and Behavioral Sciences Stanford University, School of Medicine THE DEPRESSION RESEARCH CLINIC Department of Psychiatry and Behavioral Sciences Stanford University, School of Medicine Volume 1, Issue 1 August 2007 The Depression Research Clinic at Stanford University

More information

5.07.04. Provigil Nuvigil. Provigil (modafinil) / Nuvigil (armodafinil) Description. Section: Prescription Drugs Effective Date: July 1, 2015

5.07.04. Provigil Nuvigil. Provigil (modafinil) / Nuvigil (armodafinil) Description. Section: Prescription Drugs Effective Date: July 1, 2015 Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.07.04 Subject: Provigil Nuvigil Page: 1 of 6 Last Review Date: June 19, 2015 Provigil Nuvigil Description

More information

PCORI Workshop on Treatment for Multiple Sclerosis. Breakout Group Topics and Questions Draft 3-27-15

PCORI Workshop on Treatment for Multiple Sclerosis. Breakout Group Topics and Questions Draft 3-27-15 PCORI Workshop on Treatment for Multiple Sclerosis Breakout Group Topics and Questions Draft 3-27-15 Group 1 - Comparison across DMTs, including differential effects in subgroups Consolidated straw man

More information

Antipsychotic drugs are the cornerstone of treatment

Antipsychotic drugs are the cornerstone of treatment Article Effectiveness of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in Patients With Chronic Schizophrenia Following Discontinuation of a Previous Atypical Antipsychotic T. Scott Stroup, M.D.,

More information

Study Design. Date: March 11, 2003 Reviewer: Jawahar Tiwari, Ph.D. Ellis Unger, M.D. Ghanshyam Gupta, Ph.D. Chief, Therapeutics Evaluation Branch

Study Design. Date: March 11, 2003 Reviewer: Jawahar Tiwari, Ph.D. Ellis Unger, M.D. Ghanshyam Gupta, Ph.D. Chief, Therapeutics Evaluation Branch BLA: STN 103471 Betaseron (Interferon β-1b) for the treatment of secondary progressive multiple sclerosis. Submission dated June 29, 1998. Chiron Corp. Date: March 11, 2003 Reviewer: Jawahar Tiwari, Ph.D.

More information

Gene A. Spiller, PhD, Antonella Dewell, MS, RD, Sally Chaves, RN, Zaga Rakidzich

Gene A. Spiller, PhD, Antonella Dewell, MS, RD, Sally Chaves, RN, Zaga Rakidzich TITLE Effect of daily use natural astaxanthin on C-reactive protein. Conducted by: Health Research & Studies Center, Los Altos, CA Gene A. Spiller, PhD, Antonella Dewell, MS, RD, Sally Chaves, RN, Zaga

More information

New and Emerging Immunotherapies for Multiple Sclerosis: Oral Agents

New and Emerging Immunotherapies for Multiple Sclerosis: Oral Agents New and Emerging Immunotherapies for Multiple Sclerosis: Oral Agents William Tyor, M.D. Chief, Neurology Atlanta VA Medical Center Professor, Department of Neurology Emory University School of Medicine

More information

Guidance on Investigational Medicinal Products (IMPs) and other medicinal products used in Clinical Trials

Guidance on Investigational Medicinal Products (IMPs) and other medicinal products used in Clinical Trials EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Guidance on Investigational Medicinal Products (IMPs) and other medicinal products used in Clinical Trials

More information

Oncology Nursing Society Annual Progress Report: 2008 Formula Grant

Oncology Nursing Society Annual Progress Report: 2008 Formula Grant Oncology Nursing Society Annual Progress Report: 2008 Formula Grant Reporting Period July 1, 2009 June 30, 2010 Formula Grant Overview The Oncology Nursing Society received $12,473 in formula funds for

More information

The Clinical Trials Process an educated patient s guide

The Clinical Trials Process an educated patient s guide The Clinical Trials Process an educated patient s guide Gwen L. Nichols, MD Site Head, Oncology Roche TCRC, Translational and Clinical Research Center New York DISCLAIMER I am an employee of Hoffmann-

More information

Medication Management of Depressive Disorders in Children and Adolescents. Satya Tata, M.D. Kansas University Medical Center

Medication Management of Depressive Disorders in Children and Adolescents. Satya Tata, M.D. Kansas University Medical Center Medication Management of Depressive Disorders in Children and Adolescents Satya Tata, M.D. Kansas University Medical Center First Line Medications SSRIs Prozac (Fluoxetine): 5-605 mg Zoloft (Sertraline):

More information

Tension Type Headaches

Tension Type Headaches Tension Type Headaches Research Review by : Dr. Ian MacIntyre Physiotherapy for tension-type Headache: A Controlled Study P. Torelli, R. Jenson, J. Olsen: Cephalalgia, 2004, 24, 29-36 Tension-type headache

More information

Application of Clinical Trial Certificate of Chinese Medicines in Hong Kong

Application of Clinical Trial Certificate of Chinese Medicines in Hong Kong Application of Clinical Trial Certificate of Chinese Medicines in Hong Kong D R. K F C H U N G D E P A R T M E N T O F P S Y C H I A T R Y U N I V E R S I T Y O F H O N G K O N G ( S E P T 2 0 1 4 ) Evidence-based

More information

REHABILITATION MEDICINE by PROFESSOR ANTHONY WARD

REHABILITATION MEDICINE by PROFESSOR ANTHONY WARD REHABILITATION MEDICINE by PROFESSOR ANTHONY WARD What is Rehabilitation Medicine? Rehabilitation Medicine (RM) is the medical specialty with rehabilitation as its primary strategy. It provides services

More information

Neck Pain & Cervicogenic Headache Integrating Research into Practice: San Luis Sports Therapy s Approach to Evidence-Based Practice

Neck Pain & Cervicogenic Headache Integrating Research into Practice: San Luis Sports Therapy s Approach to Evidence-Based Practice Neck Pain & Cervicogenic Headache Integrating Research into Practice: San Luis Sports Therapy s Approach to Evidence-Based Practice PROBLEM: Neck Pain and Cervicogenic Headache 66% Proportion of individuals

More information

2. FRAGESTELLUNGEN DER VORGESTELLTEN ARBEITEN 26. 3.1 Wirksamkeit der Akupunktur bei ausgewählten Schmerzerkrankungen

2. FRAGESTELLUNGEN DER VORGESTELLTEN ARBEITEN 26. 3.1 Wirksamkeit der Akupunktur bei ausgewählten Schmerzerkrankungen 2. FRAGESTELLUNGEN DER VORGESTELLTEN ARBEITEN 26 3 RELEVANTE ORIGINALARBEITEN 3.1 Wirksamkeit der Akupunktur bei ausgewählten Schmerzerkrankungen Brinkhaus B, Becker-Witt C, Jena S, Linde K, Streng A,

More information

Dry Needling Corporate Medical Policy

Dry Needling Corporate Medical Policy Dry Needling Corporate Medical Policy File name: Dry Needling File code: UM.REHAB.09 Origination: 04/2015 Last Review: New policy Next Review: 04/2016 Effective Date: 9/1/2015 Description Myofascial pain

More information

Which injectable medication should I take for relapsing-remitting multiple sclerosis?

Which injectable medication should I take for relapsing-remitting multiple sclerosis? Which injectable medication should I take for relapsing-remitting multiple sclerosis? A decision aid to discuss options with your doctor This decision aid is for you if you: Have multiple sclerosis Have

More information

Dementia: Delivering the Diagnosis

Dementia: Delivering the Diagnosis Dementia: Delivering the Diagnosis Daniel D. Christensen, M.D. Clinical Professor of Psychiatry Clinical Professor of Neurology Adjunct Professor of Pharmacology University of Utah Diagnosing Dementia

More information

Riociguat Clinical Trial Program

Riociguat Clinical Trial Program Riociguat Clinical Trial Program Riociguat (BAY 63-2521) is an oral agent being investigated as a new approach to treat chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension

More information

Case Series on Chronic Whiplash Related Neck Pain Treated with Intraarticular Zygapophysial Joint Regeneration Injection Therapy

Case Series on Chronic Whiplash Related Neck Pain Treated with Intraarticular Zygapophysial Joint Regeneration Injection Therapy Pain Physician 2007; 10:313-318 ISSN 1533-3159 Case Series Case Series on Chronic Whiplash Related Neck Pain Treated with Intraarticular Zygapophysial Joint Regeneration Injection Therapy R. Allen Hooper

More information

ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines - 2015

ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines - 2015 The Clinical Level of Care Guidelines contained on the following pages have been developed as a guide to assist care managers, physicians and providers in making medical necessity decisions about the least

More information

Medication Policy Manual. Topic: Aubagio, teriflunomide Date of Origin: November 9, 2012

Medication Policy Manual. Topic: Aubagio, teriflunomide Date of Origin: November 9, 2012 Medication Policy Manual Policy No: dru283 Topic: Aubagio, teriflunomide Date of Origin: November 9, 2012 Committee Approval Date: December 12, 2014 Next Review Date: December 2015 Effective Date: January

More information

TREATING ASPD IN THE COMMUNITY: FURTHERING THE PD OFFENDER STRATEGY. Jessica Yakeley Portman Clinic Tavistock and Portman NHS Foundation Trust

TREATING ASPD IN THE COMMUNITY: FURTHERING THE PD OFFENDER STRATEGY. Jessica Yakeley Portman Clinic Tavistock and Portman NHS Foundation Trust TREATING ASPD IN THE COMMUNITY: FURTHERING THE PD OFFENDER STRATEGY Jessica Yakeley Portman Clinic Tavistock and Portman NHS Foundation Trust Treating the untreatable? Lack of evidence base for ASPD Only

More information

Acute & Chronic Pain Management (requiring opioid analgesics) in Patients Receiving Pharmacotherapy for Opioid Addiction

Acute & Chronic Pain Management (requiring opioid analgesics) in Patients Receiving Pharmacotherapy for Opioid Addiction Acute & Chronic Pain Management (requiring opioid analgesics) in Patients Receiving Pharmacotherapy for Opioid Addiction June 9, 2011 Tufts Health Care Institute Program on Opioid Risk Management Daniel

More information

High-Dose TMS May Rapidly Reduce Suicidal Thoughts

High-Dose TMS May Rapidly Reduce Suicidal Thoughts High-Dose TMS May Rapidly Reduce Suicidal Thoughts Deborah Brauser June 10, 2014 Repetitive high-dose transcranial magnetic stimulation (rtms) is safe and rapidly decreases suicidal thoughts, new research

More information

Prior Authorization, Pharmacy and Health Case Management Information. Prior Authorization. Pharmacy Information. Health Case Management

Prior Authorization, Pharmacy and Health Case Management Information. Prior Authorization. Pharmacy Information. Health Case Management Prior Authorization, Pharmacy and Health Case Management Information The purpose of this information sheet is to provide you with details on how Great-West Life will be assessing and managing your claim

More information

placebo-controlledcontrolled double-blind, blind,

placebo-controlledcontrolled double-blind, blind, Clinical Potential of Minocycline for Depression with Psychotic Features Tsuyoshi Miyaoka Department of Psychiatry Shimane University School of Medicine Minocycline 1. Second-generation tetracycline which

More information

GUIDELINES FOR USE OF PSYCHOTHERAPEUTIC MEDICATIONS IN OLDER ADULTS

GUIDELINES FOR USE OF PSYCHOTHERAPEUTIC MEDICATIONS IN OLDER ADULTS GUIDELINES GUIDELINES FOR USE OF PSYCHOTHERAPEUTIC MEDICATIONS IN OLDER ADULTS Preamble The American Society of Consultant Pharmacists has developed these guidelines for use of psychotherapeutic medications

More information

Adjunctive psychosocial intervention. Conditions requiring dose reduction. Immediate, peak plasma concentration is reached within 1 hour.

Adjunctive psychosocial intervention. Conditions requiring dose reduction. Immediate, peak plasma concentration is reached within 1 hour. Shared Care Guideline for Prescription and monitoring of Naltrexone Hydrochloride in alcohol dependence Author(s)/Originator(s): (please state author name and department) Dr Daly - Consultant Psychiatrist,

More information

A 5-HT 6 antagonist in advanced development for the treatment of mild and moderate Alzheimer s disease: idalopirdine (Lu AE58054)

A 5-HT 6 antagonist in advanced development for the treatment of mild and moderate Alzheimer s disease: idalopirdine (Lu AE58054) A 5-HT 6 antagonist in advanced development for the treatment of mild and moderate Alzheimer s disease: idalopirdine (Lu AE58054) producti Congrès National des unités de soins, d'évaluation et de prise

More information

Outline & Objectives Clinical Assessment of the Older Patient for Driving Fitness

Outline & Objectives Clinical Assessment of the Older Patient for Driving Fitness Outline & Objectives Clinical Assessment of the Older Patient for Driving Fitness Presented by: Linda Hill, MD, MPH Professor, UC San Diego School of Medicine A collaborative effort by the Division of

More information

Clinical bottom line. For more detailed evidence on the effectiveness of injections for tennis elbow, please see the CAT on:

Clinical bottom line. For more detailed evidence on the effectiveness of injections for tennis elbow, please see the CAT on: Short Question: Specific Question: In patients presenting with acute or chronic tendinopathies, what is the incidence of harm for those receiving steroid injections compared to those receiving usual care?

More information

TENS, Electroacupuncture and Ice Massage: Comparison of Treatment for Osteoarthritis of the Knee

TENS, Electroacupuncture and Ice Massage: Comparison of Treatment for Osteoarthritis of the Knee TENS, Electroacupuncture and Ice Massage: Comparison of Treatment for Osteoarthritis of the Knee Merih Yurtkuran, Tuncer Kocagil Uludag University Medical Faculty Department of Physical Therapy and Rehabilitation,

More information

Unmet Needs for Parkinson s Disease Therapeutics

Unmet Needs for Parkinson s Disease Therapeutics Unmet Needs for Parkinson s Disease Therapeutics Coalition Against Major Diseases & FDA Workshop October 20, 2014 Caroline M Tanner MD, PhD Director, Parkinson's Disease Research Education and Clinical

More information

MANAGEMENT OF CHRONIC NON MALIGNANT PAIN

MANAGEMENT OF CHRONIC NON MALIGNANT PAIN MANAGEMENT OF CHRONIC NON MALIGNANT PAIN Introduction The Manitoba Prescribing Practices Program (MPPP) recognizes the important role served by physicians in relieving pain and suffering and acknowledges

More information

EDUCATION, INITIATIVES, AND INFORMATION RESOURCES. Exploring the Role of Complementary and Alternative Medicine in Public Health Practice and Training

EDUCATION, INITIATIVES, AND INFORMATION RESOURCES. Exploring the Role of Complementary and Alternative Medicine in Public Health Practice and Training THE JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE Volume 11, Number 5, 2005, pp. 931 936 Mary Ann Liebert, Inc. EDUCATION, INITIATIVES, AND INFORMATION RESOURCES Exploring the Role of Complementary

More information

Basic Results Database

Basic Results Database Basic Results Database Deborah A. Zarin, M.D. ClinicalTrials.gov December 2008 1 ClinicalTrials.gov Overview and PL 110-85 Requirements Module 1 2 Levels of Transparency Prospective Clinical Trials Registry

More information

Oncology Nursing Society Annual Progress Report: 2008 Formula Grant

Oncology Nursing Society Annual Progress Report: 2008 Formula Grant Oncology Nursing Society Annual Progress Report: 2008 Formula Grant Reporting Period July 1, 2011 June 30, 2012 Formula Grant Overview The Oncology Nursing Society received $12,473 in formula funds for

More information

Massage Therapy Helps Back Pain By Susan Jackson Grubb, NCMT, CNMT

Massage Therapy Helps Back Pain By Susan Jackson Grubb, NCMT, CNMT 1 By Susan Jackson Grubb, NCMT, CNMT Absenteeism, lost wages and reduced productivity due to low back pain are costly to people, companies, and corporations. It is estimated that eighty percent of Americans

More information

FREEDOM C: A 16-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C

FREEDOM C: A 16-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C FREEDOM C: A 16-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C SR in Combination with an ERA and/or a PDE-5 Inhibitor

More information

U.S. Scientific Update Aricept 23 mg Tablets. Dr. Lynn Kramer President NeuroScience Product Creation Unit Eisai Inc.

U.S. Scientific Update Aricept 23 mg Tablets. Dr. Lynn Kramer President NeuroScience Product Creation Unit Eisai Inc. U.S. Scientific Update Aricept 23 mg Tablets Dr. Lynn Kramer President NeuroScience Product Creation Unit Eisai Inc. Unmet Need in Moderate to Severe Alzheimer s Disease (AD) Ongoing clinical deterioration

More information

Treating. Multiple Sclerosis. Acupressure

Treating. Multiple Sclerosis. Acupressure Treating Multiple Sclerosis With Acupressure An Alternative To Medication and Surgery by Monte Cunningham Acupressure is intended as an adjunct to, not a substitute for, conventional medical therapy. The

More information

ACUPUNCTURE IN ALCOHOLISM TREATMENT: A RANDOMIZED OUT-PATIENT STUDY

ACUPUNCTURE IN ALCOHOLISM TREATMENT: A RANDOMIZED OUT-PATIENT STUDY Alcohol & Alcoholism Vol. 34, No. 4, pp. 629 635, 1999 ACUPUNCTURE IN ALCOHOLISM TREATMENT: A RANDOMIZED OUT-PATIENT STUDY RICHARDT SAPIR-WEISE*, MATS BERGLUND, ARNE FRANK and HANS KRISTENSON Department

More information

Primary Endpoints in Alzheimer s Dementia

Primary Endpoints in Alzheimer s Dementia Primary Endpoints in Alzheimer s Dementia Dr. Karl Broich Federal Institute for Drugs and Medical Devices (BfArM) Kurt-Georg-Kiesinger-Allee 38, D-53175 Bonn Germany Critique on Regulatory Decisions in

More information

TITLE: Acupuncture for Management of Addictions Withdrawal: Clinical Effectiveness

TITLE: Acupuncture for Management of Addictions Withdrawal: Clinical Effectiveness TITLE: Acupuncture for Management of Addictions Withdrawal: Clinical Effectiveness DATE: 09 October 2008 RESEARCH QUESTION: What is the clinical effectiveness of auricular acupuncture in the management

More information

Complementary, Alternative, or Integrative Health: What s In a Name?

Complementary, Alternative, or Integrative Health: What s In a Name? Complementary, Alternative, or Integrative Health: What s In a Name? Complementary and alternative medicine, complementary medicine, alternative medicine, integrative medicine we have all seen these terms

More information

Health History Form: Beverly Hosford, Muscle Activation Techniques Specialist

Health History Form: Beverly Hosford, Muscle Activation Techniques Specialist Health History Form: Beverly Hosford, Muscle Activation Techniques Specialist Name: Phone: Address: E-mail: Birthdate: Age: EMERGENCY CONTACT Name: Phone: Are you seeing any medical practitioners such

More information

SECTION N: MEDICATIONS. N0300: Injections. Item Rationale Health-related Quality of Life. Planning for Care. Steps for Assessment. Coding Instructions

SECTION N: MEDICATIONS. N0300: Injections. Item Rationale Health-related Quality of Life. Planning for Care. Steps for Assessment. Coding Instructions SECTION N: MEDICATIONS Intent: The intent of the items in this section is to record the number of days, during the last 7 days (or since admission/reentry if less than 7 days) that any type of injection,

More information

Outcome of Drug Counseling of Outpatients in Chronic Obstructive Pulmonary Disease Clinic at Thawangpha Hospital

Outcome of Drug Counseling of Outpatients in Chronic Obstructive Pulmonary Disease Clinic at Thawangpha Hospital Mahidol University Journal of Pharmaceutical Sciences 008; 35(14): 81. Original Article Outcome of Drug Counseling of Outpatients in Chronic Obstructive Pulmonary Disease Clinic at Thawangpha Hospital

More information

SYNOPSIS. 2-Year (0.5 DB + 1.5 OL) Addendum to Clinical Study Report

SYNOPSIS. 2-Year (0.5 DB + 1.5 OL) Addendum to Clinical Study Report Name of Sponsor/Company: Bristol-Myers Squibb Name of Finished Product: Abatacept () Name of Active Ingredient: Abatacept () Individual Study Table Referring to the Dossier (For National Authority Use

More information

Maintenance of abstinence in alcohol dependence

Maintenance of abstinence in alcohol dependence Shared Care Guideline for Prescription and monitoring of Acamprosate Calcium Author(s)/Originator(s): (please state author name and department) Dr Daly - Consultant Psychiatrist, Alcohol Services Dr Donnelly

More information

Efficacy of a Comprehensive Pain Rehabilitation Program. A Longitudinal Study. Cognitive-behavioral approach. Mayo Clinic Pain Rehabilitation Center

Efficacy of a Comprehensive Pain Rehabilitation Program. A Longitudinal Study. Cognitive-behavioral approach. Mayo Clinic Pain Rehabilitation Center Efficacy of a Compreheive Pain Rehabilitation Program with Opioid Withdrawal: A Longitudinal Study Connie Luedtke, MA, RN-BC Mayo Clinic Pain Rehabilitation Center Luedkte.connie@mayo.edu www.mayoclinic.org/pain-rehabilitation-center-rst/

More information

Minimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment:

Minimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment: Minimum Insurance Benefits for Patients with Opioid Use Disorder By David Kan, MD and Tauheed Zaman, MD Adopted by the California Society of Addiction Medicine Committee on Opioids and the California Society

More information

Audit on treatment and recovery of ankle sprain

Audit on treatment and recovery of ankle sprain Hong Kong Journal of Emergency Medicine Audit on treatment and recovery of ankle sprain WY Lee Study Objectives: The object of this study is to audit the care of ankle sprain of different severity and

More information

BOTOX Injection (Onabotulinumtoxin A) for Migraine Headaches [Preauthorization Required]

BOTOX Injection (Onabotulinumtoxin A) for Migraine Headaches [Preauthorization Required] BOTOX Injection (Onabotulinumtoxin A) for Migraine Headaches [Preauthorization Required] Medical Policy: MP-RX-01-11 Original Effective Date: March 24, 2011 Reviewed: Revised: This policy applies to products

More information

A chiropractic approach to managing migraine

A chiropractic approach to managing migraine A chiropractic approach to managing migraine What is chiropractic? Chiropractic is a primary healthcare profession that specialises in the diagnosis, treatment and overall management of conditions that

More information

A systematic study of acupuncture practice: acupoint usage in an outpatient setting in Beijing, China

A systematic study of acupuncture practice: acupoint usage in an outpatient setting in Beijing, China Complementary Therapies in Medicine (2004) 12, 209 216 A systematic study of acupuncture practice: acupoint usage in an outpatient setting in Beijing, China Vitaly Napadow a,b,, Jing Liu a, Ted J. Kaptchuk

More information

Summary of health effects

Summary of health effects Review of Findings on Chronic Disease Self- Management Program (CDSMP) Outcomes: Physical, Emotional & Health-Related Quality of Life, Healthcare Utilization and Costs Summary of health effects The major

More information

THE OFFICE OF SUBSTANCE ABUSE SERVICES REQUIREMENTS FOR THE PROVISION OF RESIDENTIAL DETOXIFICATION SERVICES BY PROVIDERS FUNDED WITH DBHDS RESOURCES

THE OFFICE OF SUBSTANCE ABUSE SERVICES REQUIREMENTS FOR THE PROVISION OF RESIDENTIAL DETOXIFICATION SERVICES BY PROVIDERS FUNDED WITH DBHDS RESOURCES THE OFFICE OF SUBSTANCE ABUSE SERVICES REQUIREMENTS FOR THE PROVISION OF RESIDENTIAL DETOXIFICATION SERVICES BY PROVIDERS FUNDED WITH DBHDS RESOURCES PURPOSE: The goal of this document is to describe the

More information

Robot-Assisted Stroke Rehabilitation

Robot-Assisted Stroke Rehabilitation American Heart Association International Stroke Conference, 2012, New Orleans Robot-Assisted Stroke Rehabilitation Albert Lo, M.D., PhD Departments of Neurology and Epidemiology Associate Director, Center

More information

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT Stroke Prevention in Atrial Fibrillation Gregory Albers, M.D. Director Stanford Stroke Center Professor of Neurology and Neurological

More information

Cochrane Review: Psychological treatments for depression and anxiety in dementia and mild cognitive impairment

Cochrane Review: Psychological treatments for depression and anxiety in dementia and mild cognitive impairment 23 rd Alzheimer Europe Conference St. Julian's, Malta, 2013 Cochrane Review: Psychological treatments for depression and anxiety in dementia and mild cognitive impairment Orgeta V, Qazi A, Spector A E,

More information

Depression, Anxiety and Acupuncture

Depression, Anxiety and Acupuncture BRIEFING PAPER No 9 Depression, Anxiety and Acupuncture The evidence for effectiveness Edited and produced by the Acupuncture Research Resource Centre Published by the British Acupuncture Council February

More information

in young people Management of depression in primary care Key recommendations: 1 Management

in young people Management of depression in primary care Key recommendations: 1 Management Management of depression in young people in primary care Key recommendations: 1 Management A young person with mild or moderate depression should typically be managed within primary care services A strength-based

More information

Resolution regarding the use of invasive procedures by physical therapists

Resolution regarding the use of invasive procedures by physical therapists Resolution regarding the use of invasive procedures by physical therapists The Arizona Acupuncture Board of Examiners (Board) is that government agency that regulates acupuncture to ensure the health,

More information

1.0 Abstract. Title: Real Life Evaluation of Rheumatoid Arthritis in Canadians taking HUMIRA. Keywords. Rationale and Background:

1.0 Abstract. Title: Real Life Evaluation of Rheumatoid Arthritis in Canadians taking HUMIRA. Keywords. Rationale and Background: 1.0 Abstract Title: Real Life Evaluation of Rheumatoid Arthritis in Canadians taking HUMIRA Keywords Rationale and Background: This abbreviated clinical study report is based on a clinical surveillance

More information

MIND-BODY THERAPIES FOR HYPERTENSION

MIND-BODY THERAPIES FOR HYPERTENSION MIND-BODY THERAPIES FOR HYPERTENSION Systematic Review and Meta-Analysis Ather Ali, ND, MPH (1), David L. Katz, MD, MPH (1,2), Michael B. Bracken, PhD, MPH (2). (1)Yale-Griffin Prevention Research Center

More information

SEVEN COMMON HEALTH SYMPTOMS

SEVEN COMMON HEALTH SYMPTOMS NADA ACUPUNCTURE PROSPECTIVE TRIAL IN PATIENTS WITH SUBSTANCE USE DISORDERS AND SEVEN COMMON HEALTH SYMPTOMS Kenneth O. Carter*, M.D., M.P.H., Dipl.Ac., Michelle Olshan- Perlmutter*, PMHCNS- BC, FNP- BC,

More information

SUBSTANCE USE DISORDER SOCIAL DETOXIFICATION SERVICES [ASAM LEVEL III.2-D]

SUBSTANCE USE DISORDER SOCIAL DETOXIFICATION SERVICES [ASAM LEVEL III.2-D] SUBSTANCE USE DISORDER SOCIAL DETOXIFICATION SERVICES [ASAM LEVEL III.2-D] I. Definitions: Detoxification is the process of interrupting the momentum of compulsive drug and/or alcohol use in an individual

More information

Acupuncture. Key Points

Acupuncture. Key Points Acupuncture Any decision you make about your health care is important including deciding whether to use acupuncture. The National Center for Complementary and Alternative Medicine (NCCAM) has developed

More information